Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off. [Phase 4]
Phase 4 trial comparing Comtess (entacapone) versus Cabaseril (cabergoline) as add-ons to levodopa in Parkinson's disease patients with wear…
-
FDA approval · 2007-06-19FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Carbidopa and Levodopa from Teva Pharmaceuticals USA, Inc. The approval updates labeling and/or …
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. [Phase 4]
A Phase 4 trial evaluating Cabaser (cabergoline) in combination with Sinemet CR for nighttime symptoms in Parkinson's disease was terminated…
-
FDA approval · 2007-05-09FDA Approved: NEUPRO — Original Application (UCB, Inc.)
FDA approved NEUPRO (rotigotine) transdermal patch from UCB, Inc. under NDA021829 for the treatment of Parkinson's disease and restless legs…
-
CLINICAL_TRIALS research · 2007-05-07Clinical Trial Update: Galantamine Executive Function in Parkinson's Disease [NA]
This is a clinical trial update examining galantamine for executive function in Parkinson's disease. The current status of the trial is list…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Functional Characterization of Parkin + Patients
A terminated clinical trial examining the functional characterization of Parkin-positive patients in Parkinson's disease. The provided snipp…
-
FDA approval · 2007-03-26FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for Dr. Reddy's Laboratories' Carbidopa and Levodopa product. The action supports a supplemental…
-
CLINICAL_TRIALS trial_result · 2007-03-06Clinical Trial Update: Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating motor cortex stimulation as a treatment for advanced Parkinson disease, assessing safety and effica…
-
FDA approval · 2007-01-24FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease [Phase 3]
Pfizer's open-label Phase 3 trial of sumanirole for Parkinson disease was terminated. The update covers safety, tolerability, and therapeuti…
-
FDA approval · 2007-01-12FDA Approved: AMANTADINE — Supplemental Application (AvPAK)
The FDA approved a supplemental application for Amantadine from AvPAK under an ANDA. This action updates the regulatory status of this produ…
-
CLINICAL_TRIALS trial_result · 2006-11-30Clinical Trial Update: STN-Stimulation Versus Best Medical Treatment in Advanced PD [Phase 3]
A Phase 3 trial comparing subthalamic nucleus stimulation to best medical therapy in advanced Parkinson's disease has completed, with the st…
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Electronic Compliance Monitoring in Parkinson's Disease [NA]
A clinical trial evaluating electronic compliance monitoring in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-10-06Clinical Trial Update: Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson's Disease
Update on a clinical trial assessing whether higher exercise intensity can slow progression in early Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2006-09-22Clinical Trial Update: The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease [Phase 2]
Pfizer-sponsored Phase 2 trial of the NR2B NMDA antagonist Traxoprodil (CP-101,606) in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: Parkinson's Disease Evaluated by PET and the Effect of Memantine [NA]
A completed clinical trial evaluated Parkinson's disease using PET imaging and assessed the effect of memantine. The study was sponsored by …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Chinese Exercise Modalities in Parkinson's Disease [Phase 1, Phase 2]
NCCIH-sponsored Phase 1/2 clinical trial evaluating Chinese exercise modalities for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Magnetic Stimulation for Parkinson Disease [Phase 1]
Phase 1 clinical trial of magnetic stimulation for Parkinson's disease has completed; the study also includes depression as a condition.
-
FDA approval · 2006-08-15FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approval of a supplemental application for a generic bromocriptine mesylate product by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
A clinical trial evaluating deep brain stimulation for depression and quality of life in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-26Clinical Trial Update: Valerian to Improve Sleep in Patients With Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluated valerian for improving sleep in patients with Parkinson's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-13Clinical Trial Update: Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System [Phase 2]
Phase 2 clinical trial evaluating dextromethorphan for Parkinson's disease and related neurodegenerative conditions has completed.
-
CLINICAL_TRIALS research · 2006-06-23Clinical Trial Update: Sensory Cues for Freezing in Parkinson's Disease [NA]
This record provides an update on a clinical trial investigating sensory cues to address freezing episodes in Parkinson's disease.
-
FDA approval · 2006-06-14FDA Approved: ZELAPAR — Original Application (Bausch Health US, LLC)
FDA approved Zelapar (selegiline hydrochloride) through the original NDA submission by Bausch Health US, LLC for its indicated use.
-
CLINICAL_TRIALS trial_result · 2006-06-07Clinical Trial Update: Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating Sumanirole for early Parkinson's disease has completed.